scispace - formally typeset
N

Naomi F. Walker

Researcher at University of London

Publications -  35
Citations -  2444

Naomi F. Walker is an academic researcher from University of London. The author has contributed to research in topics: Tuberculosis & Ebola virus. The author has an hindex of 20, co-authored 34 publications receiving 1557 citations. Previous affiliations of Naomi F. Walker include Imperial College London & University College Hospital.

Papers
More filters
Journal ArticleDOI

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

Victoria Hall, +353 more
- 08 May 2021 - 
TL;DR: The SIREN study as discussed by the authors showed that the BNT162b2 vaccine can prevent both symptomatic and asymptomatic infection in working-age adults in the UK.
Journal ArticleDOI

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

V J Hall, +305 more
- 17 Apr 2021 - 
TL;DR: The SARS-CoV-2 Immunity and Reinfection Evaluation study as mentioned in this paper showed that a previous history of SARS infection was associated with an 84% lower risk of infection, with median protective effect observed 7 months following primary infection.
Journal ArticleDOI

MMP-1 drives immunopathology in human tuberculosis and transgenic mice

TL;DR: MMP-1 may drive tissue destruction in TB and represents a therapeutic target to limit immunopathology, according to patients with TB and symptomatic controls.
Journal ArticleDOI

Immune reconstitution inflammatory syndrome in HIV-infected patients

TL;DR: An overview of clinical and epidemiological features of HIV-associated IRIS, current understanding of pathophysiological mechanisms, available therapy, and preventive strategies, and a particular focus on three important pathogen-associated forms.
Journal ArticleDOI

Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases

TL;DR: Doxycycline decreases MMP activity in a cellular model and suppresses mycobacterial growth in vitro and in guinea pigs, and adjunctive doxycycline therapy may reduce morbidity and mortality in TB.